Association between gene expression profiles and clinical outcome of pemetrexed-based treatment in patients with advanced non-squamous non-small cell lung cancer: exploratory results from a phase II study. [electronic resource]
Producer: 20150623Description: e107455 p. digitalISSN:- 1932-6203
- Adenocarcinoma -- drug therapy
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cisplatin -- administration & dosage
- Cluster Analysis
- Disease-Free Survival
- Female
- Gene Expression Regulation, Neoplastic -- drug effects
- Glutamates -- administration & dosage
- Guanine -- administration & dosage
- Humans
- Immunohistochemistry
- Kaplan-Meier Estimate
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Oligonucleotide Array Sequence Analysis
- Outcome Assessment, Health Care -- methods
- Pemetrexed
- Prognosis
- Proportional Hazards Models
- Thymidylate Synthase -- genetics
- Transcriptome -- drug effects
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.